Akoya Biosciences (AKYA)
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics i...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 1.290
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- Quartr · 23 hours ago
QTRX: Diagnostics and clinical trials growth, new leadership, and synergy gains drive optimism for 2024
- TradingView · Aug 10 at 07:41 AM
Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q Summary
- StockTitan · Apr 23 at 11:35 PM
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026 | QTRX Stock News
- StockTitan · Feb 19 at 11:33 PM
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026 | QTRX Stock News
- StockTitan · Jul 8, 2025 at 08:07 AM
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum | QTRX Stock News
- prnewswire · Jun 20, 2025 at 05:19 PM
18:18 ET AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
